Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) — Cash Flow Reinvestment Rate
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) has a Cash Flow Reinvestment Rate of 3.98x as of December 2024, reinvesting CN¥503.43 Million (capex CN¥115.96 Million plus investments CN¥-387.47 Million) from operating cash flow of CN¥126.49 Million. See Jiangsu Canopus Wisdom Medical Technolog free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A across 5 annual periods. For the full cash flow conversion analysis, see Jiangsu Canopus Wisdom Medical Technolog (301290) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (2020–2024)
Year-by-year capital reinvestment analysis for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A. See 301290 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.98x | CN¥503.43 Million | CN¥126.49 Million | CN¥115.96 Million | ▲ +2.0% |
| 2023 | 3.90x | CN¥636.51 Million | CN¥163.13 Million | CN¥111.46 Million | ▲ +162.4% |
| 2022 | 1.49x | CN¥140.72 Million | CN¥94.63 Million | CN¥74.35 Million | ▲ +142.4% |
| 2021 | 0.61x | CN¥100.25 Million | CN¥163.45 Million | CN¥95.67 Million | ▼ -76.8% |
| 2020 | 2.64x | CN¥301.35 Million | CN¥114.07 Million | CN¥25.43 Million | — |